Many pharma and biotech companies are also focusing in on Trump’s proposal to allow U.S. pharmaceutical companies to repatriate foreign cash at a 10 percent tax rate (rather than the current 35 percent tax rate), which would potentially increase both profit and growth opportunities for the sector.
3 Sectors That Are Likely to Benefit from Trump
